Diagnostic Value of Preoperative uPAR-PET/CT in Regional Lymph Node Staging of Oral and Oropharyngeal Squamous Cell Carcinoma: A Prospective Phase II Trial

Keyphrases

• Phase II Trial 100%
• Diagnostic Value 100%
• Regional Lymph Nodes 100%
• Positron Emission tomography-CT 100%
• Lymph Node Staging 100%
• Prospective Phase II Study 100%
• Oropharyngeal Squamous Cell Carcinoma (OPSCC) 100%
• Urokinase-type Plasminogen Activator Receptor (uPAR) 100%
• Metastatic Disease 33%
• 68Ga-NOTA-AE105 33%
• Lymph Node Metastasis 25%
• Receptor Expression 16%
• Primary Tumor 16%
• Lymph Node 16%
• SUVmax 16%
• Target Specificity 16%
• H-score 16%
• Positron Emission Tomography/computed Tomography (PET/CT) 16%
• CT-like MRI 16%
• Immunohistochemistry 8%
• Surgical Treatment 8%
• Computed Tomography 8%
• Histology 8%
• High Affinity 8%
• Tumor Cells 8%
• Radioligand 8%
• Before Surgery 8%
• Imaging Results 8%
• Intraoperative Imaging 8%
• Occult Metastasis 8%
• Neck Dissection 8%
• Tumor Depth 8%
• Gallium-68 8%
• Current Imaging 8%
• Nodal Staging 8%
• SUVmax Values 8%
• Major Challenges 8%
• Primary Metastases 8%

Medicine and Dentistry

• Lymph Node 100%
• Urokinase Receptor 100%
• Positron Emission Tomography 100%
• Phase II Trials 100%
• Mouth Squamous Cell Carcinoma 100%
• Oropharynx Squamous Cell Carcinoma 100%
• Metastatic Carcinoma 50%
• Gallium 68 41%
• Magnetic Resonance Imaging 25%
• Lymph Node Metastasis 25%
• Sensitivity and Specificity 16%
• Receptor Expression 16%
• Primary Tumor 16%
• Neoplasm 8%
• Computer Assisted Tomography 8%
• Tumor Cell 8%
• Receptor 8%
• Immunohistochemistry 8%
• Radioligand 8%
• Neck Dissection 8%
• Surgery 8%
• Preoperative Imaging 8%
• Histology 8%